TLPH
What one share of Talphera holds
Pharmaceutical Preparations
We are a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings.
Talphera’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.24 |
| Cash and investments | $0.01 |
| Book value | $0.28 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $7.66 | −$19.05 | $1.64 | −$14.62 | — | −$2.35 |
| 2017 | $3.41 | −$21.97 | $1.03 | −$13.72 | — | −$14.35 |
| 2018 | $0.74 | −$16.14 | $0.28 | −$10.24 | — | $1.08 |
| 2019 | $0.58 | −$13.45 | $0.88 | −$13.80 | — | −$10.41 |
| 2020 | $1.27 | −$9.47 | $0.44 | −$9.47 | — | −$11.28 |
| 2021 | $0.47 | −$5.86 | $0.30 | −$5.31 | — | −$5.25 |
| 2022 | $0.00 | $5.72 | $0.05 | −$3.87 | — | $2.65 |
| 2023 | $0.05 | −$1.29 | $0.01 | −$1.23 | — | $0.83 |
| 2024 | $0.00 | −$0.50 | $0.00 | −$0.49 | — | $0.47 |
| 2025 | $0.00 | −$0.34 | — | −$0.27 | — | $0.35 |